
Collaboration - February 12, 2014
New European program targets novel antibiotics
More than 30 European universities and companies are joining forces in a 6 year programme funded by the Innovative Medicines Initiative (IMI) to develop novel antibiotics. The initiative is led by GlaxoSmithKline and Uppsala University. The novel antibiotics are being developed against Gram-negative pathogens in a project called ENABLE (European Gram Negative Antibacterial Engine). The ENABLE […]